Re: ventana nexes - her2neu
|From:||ANN MARUSKA <amarusk1@FAIRVIEW.ORG>|
I was recently at the NSH and that specific question came up......is the Herceptest the only test approved that will allow the patient to receive the Herceptin therapy. The answer was a resounding no! Any test that proves there is over amplification of the protein or a test that proves one has the gene qualifies the patient to recieve Herceptin therapy.
Ventana hope to have their CB-11 antibody FDA approved within a very short period of time. The CB-11 has been shown to have very good correlation with FISH Her2.
Dr. Allred who spoke at the Culling Memorial lecture had some very good statistics on this. I believe you may contact him thru his email for this info:
"firstname.lastname@example.org" The lecture was about prognostic & predictive factors on breast cancers.
Fairview-University Medical Center
Mpls. MN 55454
<< Previous Message | Next Message >>